Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Samsung Biologics | Seoul | Healthcare | Pharmaceuticals | ₩75.37T | 69.1x | 2.61 | ₩1,049,000 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 22.8% Upside | Upgrade to Pro+ | |
Alteogen | KOSDAQ | Healthcare | Pharmaceuticals | ₩20.04T | 315.6x | 0.17 | ₩393,000 | 4.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Yuhan | Seoul | Healthcare | Pharmaceuticals | ₩8.58T | 126.9x | -2.42 | ₩102,600 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Yuhan | Seoul | Healthcare | Pharmaceuticals | ₩8.58T | 126.9x | -2.42 | ₩115,400 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 39.5% Upside | Upgrade to Pro+ | |
Sk Biopharma | Seoul | Healthcare | Pharmaceuticals | ₩8.14T | 33.2x | 0.04 | ₩104,800 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 42.6% Upside | Upgrade to Pro+ | |
Pharma Reaserch Products | KOSDAQ | Healthcare | Pharmaceuticals | ₩3.77T | 37.5x | 2.13 | ₩367,500 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -7.6% Downside | Upgrade to Pro+ | |
Hugel | KOSDAQ | Healthcare | Pharmaceuticals | ₩3.69T | 27.8x | 0.53 | ₩340,000 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 16.8% Upside | Upgrade to Pro+ | |
Sam Chun Dang Pharm | KOSDAQ | Healthcare | Pharmaceuticals | ₩3.48T | -308.7x | ₩153,600 | 2.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
SK Bioscience Co | Seoul | Healthcare | Pharmaceuticals | ₩3.07T | -56.5x | 0.17 | ₩39,100 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 5.1% Upside | Upgrade to Pro+ | |
Hanmi Pharm Co | Seoul | Healthcare | Pharmaceuticals | ₩2.99T | 23.6x | -1.5 | ₩239,500 | 1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Celltrion Pharm | KOSDAQ | Healthcare | Pharmaceuticals | ₩2.09T | 90.9x | ₩47,200 | -1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Hanmi Science | Seoul | Healthcare | Pharmaceuticals | ₩1.89T | 30.5x | -0.67 | ₩28,100 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nature Cell | KOSDAQ | Healthcare | Pharmaceuticals | ₩1.75T | 1,587.1x | 15.34 | ₩26,600 | -2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ST Pharm | KOSDAQ | Healthcare | Pharmaceuticals | ₩1.53T | 41.2x | 0.62 | ₩76,600 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Daewoong Pharma | Seoul | Healthcare | Pharmaceuticals | ₩1.5T | 56.2x | -0.77 | ₩131,500 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hanall Biopharma | Seoul | Healthcare | Pharmaceuticals | ₩1.4T | -802.2x | 5.09 | ₩27,250 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
GC Biopharma | Seoul | Healthcare | Pharmaceuticals | ₩1.36T | -51.3x | -38.16 | ₩119,600 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Caregen | KOSDAQ | Healthcare | Pharmaceuticals | ₩1.27T | 39.5x | -2.13 | ₩25,550 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 46.4% Upside | Upgrade to Pro+ | |
Oscotec | KOSDAQ | Healthcare | Pharmaceuticals | ₩1.18T | 1,245.7x | 13.35 | ₩30,400 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Mezzion Pharma | KOSDAQ | Healthcare | Pharmaceuticals | ₩1.11T | -51.5x | 1.23 | ₩37,050 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medy-Tox | KOSDAQ | Healthcare | Pharmaceuticals | ₩1.09T | 61x | 0.77 | ₩163,300 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 33.3% Upside | Upgrade to Pro+ | |
HK Inno.N | KOSDAQ | Healthcare | Pharmaceuticals | ₩1.05T | 25x | ₩37,400 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Chong Kun Dang Pharma | Seoul | Healthcare | Pharmaceuticals | ₩1.04T | 9.1x | -0.2 | ₩78,700 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Daewoong | Seoul | Healthcare | Pharmaceuticals | ₩808.82B | 14x | -0.22 | ₩19,800 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 41.6% Upside | Upgrade to Pro+ | |
HLB Life Science | KOSDAQ | Healthcare | Pharmaceuticals | ₩780.88B | 112.4x | 0.62 | ₩6,280 | -2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Boryung Pharm | Seoul | Healthcare | Pharmaceuticals | ₩712.85B | 8.5x | 0.15 | ₩8,570 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
HLB Therapeutics | KOSDAQ | Healthcare | Pharmaceuticals | ₩689.5B | -30.4x | 0.03 | ₩8,030 | -2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Dongkook Pharmaceutical | KOSDAQ | Healthcare | Pharmaceuticals | ₩668.76B | 10.7x | 0.36 | ₩15,290 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Donga Socio Holdings | Seoul | Healthcare | Pharmaceuticals | ₩634.81B | 10.9x | ₩98,100 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 42.8% Upside | Upgrade to Pro+ | ||
Green Cross Holdings | Seoul | Healthcare | Pharmaceuticals | ₩609.41B | 24.1x | 0.17 | ₩20,800 | -2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Green Cross | Seoul | Healthcare | Pharmaceuticals | ₩609.41B | 24.1x | 0.17 | ₩13,370 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Huons Global | KOSDAQ | Healthcare | Pharmaceuticals | ₩571.85B | 21.4x | -0.65 | ₩48,550 | 3.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Pharmicell | Seoul | Healthcare | Pharmaceuticals | ₩566.44B | -18.6x | ₩9,710 | 2.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Binex | KOSDAQ | Healthcare | Pharmaceuticals | ₩510.52B | -13.7x | 0.01 | ₩15,970 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
JW Pharmaceutical | Seoul | Healthcare | Pharmaceuticals | ₩497.77B | 7.2x | 0.1 | ₩27,500 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
JW Pharmaceutical | Seoul | Healthcare | Pharmaceuticals | ₩497.77B | 7.2x | 0.1 | ₩59,900 | 2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Jw Pharmac | Seoul | Healthcare | Pharmaceuticals | ₩497.77B | 7.2x | 0.1 | ₩22,000 | 2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BioPlus | KOSDAQ | Healthcare | Pharmaceuticals | ₩459.28B | 26.8x | -0.77 | ₩7,860 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CMG Pharmaceutical | KOSDAQ | Healthcare | Pharmaceuticals | ₩413.2B | 335.7x | -1.21 | ₩2,735 | -8.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Dong-A St | Seoul | Healthcare | Pharmaceuticals | ₩410.97B | -306.6x | 2.94 | ₩45,000 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Humedix | KOSDAQ | Healthcare | Pharmaceuticals | ₩409.26B | 43x | ₩39,600 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Eubiologics | KOSDAQ | Healthcare | Pharmaceuticals | ₩406.26B | -29.8x | ₩11,230 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Shinpoong Pharmaceutical Co | Seoul | Healthcare | Pharmaceuticals | ₩396.63B | -22.1x | -0.33 | ₩12,250 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Shinpoong Phar | Seoul | Healthcare | Pharmaceuticals | ₩396.63B | -22.1x | -0.33 | ₩7,570 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Yungjin Pharm | Seoul | Healthcare | Pharmaceuticals | ₩367.61B | 38x | ₩2,005 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Komipharm Intl | KOSDAQ | Healthcare | Pharmaceuticals | ₩358.25B | 23.5x | 0.06 | ₩5,090 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Kolon Life Science | KOSDAQ | Healthcare | Pharmaceuticals | ₩346.61B | -3.3x | 0.02 | ₩27,750 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Prestige Biologics Co | KOSDAQ | Healthcare | Pharmaceuticals | ₩313.93B | -6.7x | ₩4,170 | 2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Il Dong Pharma | Seoul | Healthcare | Pharmaceuticals | ₩313.12B | -68.8x | -0.72 | ₩11,330 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Vivozon Healthcare | KOSDAQ | Healthcare | Pharmaceuticals | ₩312.08B | -25.4x | 0.15 | ₩6,900 | 9.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |